Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of Astrazeneca Pharma India Limited appointed Ms. Shikha Mirchandani Chatrath as Director - Commercial Excellence, BD & Strategy with effect from June 17, 2024. Ms. Shikha Mirchandani Chatrath is a professional with 12 years of experience in commercial, consulting and strategy. She has experience of leading global strategy and business transformations projects with Market and global CXOs. She also
has exposure of working across geographies namely India, UK, Belgium, Switzerland, Mauritius, Singapore & UAE. Currently, she is the Business Head Urology India and South
Asia, Boston Scientific. In this role, she is responsible for business revenue and profitability performance, and market share for the entire Urology and CO2 laser business for India
and South Asia region. Prior to Business Head role at Boston Scientific, she has performed multiple commercial, strategy, business development and consulting roles at Philips India and Accenture Management Consulting. Ms. Shikha is M.B. A (PGDM) from Indian Institute of Management Calcutta and B.E. Hons Computer Science, from BITS Pilani, Dubai.